Bioscience Biotechnology and Biochemistry · 1999 · 13 citations · 12 references
Life SciencesBiochemistryPharmacologyChemotherapyDna RepairEnzymologyDna DamageDna LigaseEnzyme InhibitionTopoisomerase InhibitorsCatalytic Topoisomerase InhibitionDna CleavageDna Cleavage MechanismDna Damage InductionDna Topoisomerase I InhibitionT4 Dna LigaseTopoisomerase ActivityTopoisomerase I Inhibitors
Dihydrotanshinone I induced topoisomerase I-mediated DNA cleavage in vitro as strongly as camptothecin, but topoisomerase II-mediated DNA cleavage was not affected. In a DNA relaxation assay using calf thymus DNA topoisomerase I and supercoiled pBR322 plasmid DNA, dihydrotanshinone I reduced topoisomerase I-mediated DNA relaxation in a dose-dependent manner. Heat treatment (65°C) of the reaction mixture containing dihydrotanshinone I and topoisomerase I resulted in a substantial reduction in DNA cleavage, suggesting topoisomerase I and dihydrotanshinone I may form a reversible cleavable complex to induce DNA damage. A DNA unwinding assay using T4 DNA ligase showed that dihydrotanshinone I is a very weak DNA intercalator. These results suggest that dihydrotanshinone I inhibits the catalytic activity of topoisomerase I by the formation of a cleavable complex and at least in part through the intercalation into DNA.
12
DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues.
Y H Hsiang, Leroy F. Liu, Monroe E. Wall et al. · PubMed · 1989 · 341 citations
Medicine, Oncology, Pharmacology +13